Close Menu

NEW YORK (GenomeWeb) – Biogen Idec and Columbia University Medical Center today announced they have signed a $30 million agreement to establish a research facility to study the genetics of disease and find new drug targets.

The partners will build a sequencing and analysis facility and create a postdoctoral program at Columbia to support collaborative genetics studies. The agreement, they said, brings together genomics research conducted at Columbia with Biogen's expertise in discovering new medicines.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.